StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3083% above fair value
$272.70−6.00 (-2.15%)

Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%

Johnson & Johnson revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Johnson & Johnson's revenue for the twelve months ending Sep 27, 2026 was $99.34B, up 7.8% year over year. For fiscal 2025 it was $94.19B, up 6.0% from the year before. Over ten years it grew 3.0% a year on average. The highest annual figure on record is $94.19B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 28, 2025$94.19B+6.0%
FY2024Dec 29, 2024$88.82B+4.3%
FY2023Dec 31, 2023$85.16B+6.5%
FY2022Jan 1, 2023$79.99B+1.6%
FY2021Jan 2, 2022$78.74B-4.7%
FY2020Jan 3, 2021$82.58B+0.6%
FY2019Dec 29, 2019$82.06B+0.6%
FY2018Dec 30, 2018$81.58B+6.7%
FY2017Dec 31, 2017$76.45B+6.3%
FY2016Jan 1, 2017$71.89B+2.6%
FY2015Jan 3, 2016$70.07B-5.7%
FY2014Dec 28, 2014$74.33B+4.2%
FY2013Dec 29, 2013$71.31B+6.1%
FY2012Dec 30, 2012$67.22B+3.4%
FY2011Jan 1, 2012$65.03B+5.6%
FY2010Jan 2, 2011$61.59B-0.5%
FY2009Jan 3, 2010$61.90B-2.9%
FY2008Dec 28, 2008$63.75B+4.3%
FY2007Dec 30, 2007$61.10B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$25.40B+5.9%
Q2 FY2026Jun 28, 2026$25.31B+6.6%
Q1 FY2026Mar 29, 2026$24.06B+9.9%
Q4 FY2025Dec 28, 2025$24.56B+9.1%
Q3 FY2025Sep 28, 2025$23.99B+6.8%
Q2 FY2025Jun 29, 2025$23.74B+5.8%
Q1 FY2025Mar 30, 2025$21.89B+2.4%
Q4 FY2024Dec 29, 2024$22.52B+5.3%
Q3 FY2024Sep 29, 2024$22.47B+5.2%
Q2 FY2024Jun 30, 2024$22.45B+4.3%
Q1 FY2024Mar 31, 2024$21.38B+2.3%
Q4 FY2023Dec 31, 2023$21.40B+7.3%
Q3 FY2023Oct 1, 2023$21.35B+6.8%
Q2 FY2023Jul 2, 2023$21.52B+6.5%
Q1 FY2023Apr 2, 2023$20.89B+5.3%
Q4 FY2022Jan 1, 2023$19.94B+104.1%
Q3 FY2022Oct 2, 2022$20.00B-14.3%
Q2 FY2022Jul 3, 2022$20.22B-13.3%
Q1 FY2022Apr 3, 2022$19.84B-11.1%
Q4 FY2021Jan 2, 2022$9.77B-56.5%
Q3 FY2021Oct 3, 2021$23.34B+10.7%
Q2 FY2021Jul 4, 2021$23.31B+27.1%
Q1 FY2021Apr 4, 2021$22.32B+7.9%
Q4 FY2020Jan 3, 2021$22.48B+8.3%
Q3 FY2020Sep 27, 2020$21.08B+1.7%
Q2 FY2020Jun 28, 2020$18.34B-10.8%
Q1 FY2020Mar 29, 2020$20.69B+3.3%
Q4 FY2019Dec 29, 2019$20.75B+1.7%
Q3 FY2019Sep 29, 2019$20.73B+1.9%
Q2 FY2019Jun 30, 2019$20.56B-1.3%
Q1 FY2019Mar 31, 2019$20.02B+0.1%
Q4 FY2018Dec 30, 2018$20.39B+1.0%
Q3 FY2018Sep 30, 2018$20.35B+3.6%
Q2 FY2018Jul 1, 2018$20.83B+10.6%
Q1 FY2018Apr 1, 2018$20.01B+12.6%
Q4 FY2017Dec 31, 2017$20.20B+11.5%
Q3 FY2017Oct 1, 2017$19.65B–
Q2 FY2017Jul 2, 2017$18.84B–
Q1 FY2017Apr 2, 2017$17.77B–
Q4 FY2016Jan 1, 2017$18.11B–

More Johnson & Johnson figures

See a number that looks wrong?